Participant flow

A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma · Source last updated 2019-07-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Participants with completely resected Stage IIC, IIIA, or IIIB cutaneous melanoma) received vemurafenib, 960 milligrams (mg) twice daily, in 28-day cycles, for up to 52 weeks

   id

   FG000

   title

   Cohort 1 Vemurafenib

2. description

   Participants with completely resected Stage IIC, IIIA, or IIIB cutaneous melanoma) received vemurafenib-matching placebo twice daily, in 28-day cycles, for up to 52 weeks

   id

   FG001

   title

   Cohort 1 Placebo

3. description

   Participants with Stage IIIC cutaneous melanoma received vemurafenib, 960 mg twice daily, in 28-day cycles, for up to 52 weeks

   id

   FG002

   title

   Cohort 2 Vemurafenib

4. description

   Participants with Stage IIIC cutaneous melanoma received vemurafenib-matching placebo twice daily, in 28-day cycles, for up to 52 weeks

   id

   FG003

   title

   Cohort 2 Placebo

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         0

      type

      Reason Not Specified

   2. reasons

      1. group Id

         FG000

         num Subjects

         16

      2. group Id

         FG001

         num Subjects

         8

      3. group Id

         FG002

         num Subjects

         9

      4. group Id

         FG003

         num Subjects

         8

      type

      Withdrawal by Subject

   3. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         1

      type

      Non-compliance

   4. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         0

      type

      Protocol Violation

   5. reasons

      1. group Id

         FG000

         num Subjects

         7

      2. group Id

         FG001

         num Subjects

         6

      3. group Id

         FG002

         num Subjects

         2

      4. group Id

         FG003

         num Subjects

         4

      type

      Lost to Follow-up

   6. reasons

      1. group Id

         FG000

         num Subjects

         18

      2. group Id

         FG001

         num Subjects

         33

      3. group Id

         FG002

         num Subjects

         25

      4. group Id

         FG003

         num Subjects

         26

      type

      Death

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         157

      2. group Id

         FG001

         num Subjects

         157

      3. group Id

         FG002

         num Subjects

         93

      4. group Id

         FG003

         num Subjects

         91

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         114

      2. group Id

         FG001

         num Subjects

         110

      3. group Id

         FG002

         num Subjects

         57

      4. group Id

         FG003

         num Subjects

         52

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         43

      2. group Id

         FG001

         num Subjects

         47

      3. group Id

         FG002

         num Subjects

         36

      4. group Id

         FG003

         num Subjects

         39

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice